GTS Securities’s GSK GSK Stock Holding History

GTS Securities’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,054	Closed	-$386K	–	1531
2025 Q2	$386K	Buy	10,054 +4,254	+73%	+$163K	0.02%	779
2025 Q1	$225K	Buy	+5,800	New	+$212K	0.01%	1101
2024 Q1	–	Sell	-109,351	Closed	-$4.51M	–	4097
2023 Q4	$4.05M	Sell	109,351 -90,034	-45%	-$3.23M	0.01%	1150
2023 Q3	$7.23M	Buy	199,385 +55,654	+39%	+$1.98M	0.01%	743
2023 Q2	$5.12M	Buy	+143,731	New	+$5.16M	0.16%	122

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GTS Securities's GSK Position: Q3 2025 in Review

GTS Securities sold out of GSK (GSK) in Q3 2025, closing a stake of 10,054 shares — an estimated $386K sold.

GTS Securities first reported a position in GSK in Q2 2023 and held it in 5 quarters. The position peaked at $7.23M in Q3 2023. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

GTS Securities reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
GTS Securities sold 10,054 GSK shares in Q3 2025, an estimated $386K.
GTS Securities first reported a position in GSK in Q2 2023 and held it in 5 quarters.
GTS Securities's GSK position peaked at $7.23M in Q3 2023.
895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on GTS Securities's 13F filing for Q3 2025, filed 14 Nov 2025.